What's new? Log in Free sign up

Alcon (ALC)

Company Profile

Company profile

Ticker

ALC

Exchange

Website

CEO

Mr. David J. Endicott

Incorporated

Location

Fiscal year end

Sector

Health Care and Social Assistance > Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

Industry (SIC)

Ophthalmic Goods

Bausch + Lomb • The Cooper Companies, Inc. • National Vision • Warby Parker • Ceres Tactical Systematic • U. S. Premium Beef • RxSight • STAAR Surgical • Strong Global Entertainment • Learn CW Investment ...

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

ALC stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$105.50

Low target

$105.00

High target

$106.00

Latest filings (excl ownership)

View all

Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation

Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses

Alcon’s Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance

Conflict minerals disclosure

Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health

Alcon Publishes Agenda for 2024 Annual General Meeting

Current report (foreign)

Annual report (foreign)

27 Feb 24

Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023

Alcon Reports Third Quarter 2023 Results

Transcripts

View all

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Latest ownership filings

View all

Notice of proposed sale of securities

Notice of proposed sale of securities

Notice of proposed sale of securities

Notice of proposed sale of securities

Notice of proposed sale of securities

Notice of proposed sale of securities

Notice of proposed sale of securities

Notice of proposed sale of securities

Notice of proposed sale of securities

Notice of proposed sale of securities

Financial summary

Financial statements Chart ALC financial data

Quarter (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Alcon earnings reports.

Institutional ownership, Q3 2024

ALC institutional ownership history Ownership history

49.1% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	636	619	+2.7%
Opened positions	84	91	-7.7%
Closed positions	67	58	+15.5%
Increased positions	182	190	-4.2%
Reduced positions	226	199	+13.6%

13F shares	Current	Prev Q	Change
Total value	22.33 tn	20.38 tn	+9.5%
Total shares	242.37 mm	253.06 mm	-4.2%
Total puts	1.65 mm	2.06 mm	-20.1%
Total calls	2.35 mm	2.51 mm	-6.3%
Total put/call ratio	0.7	0.8	-14.7%

Largest owners	Shares	Value	Change
Vanguard	19.37 mm	$1.94 tn	+1.3%
FMR	14.37 mm	$1.43 tn	+29.3%
Ubs Global Asset Management Americas	12.05 mm	$1.21 tn	-14.9%
Aristotle Capital Management	11.87 mm	$1.19 tn	-1.2%
Harding Loevner	9.27 mm	$927.68 bn	-4.0%
Zurcher Kantonalbank	8.62 mm	$862.06 bn	+1.0%
BK The Bank of New York Mellon Corporation	7.80 mm	$780.83 bn	+13.2%
Vontobel Holding	7.37 mm	$734.64 bn	-6.9%
Clearbridge Advisors	7.26 mm	$726.55 bn	-19.7%
T. Rowe Price Investment Management	6.39 mm	$639.48 mm	-1.0%

Largest transactions	Shares	Bought/sold	Change
Norges Bank	0.00	-12.35 mm	EXIT
Select Equity	5.38 mm	+5.38 mm	NEW
BCS Barclays	1.52 mm	-4.84 mm	-76.1%
FMR	14.37 mm	+3.25 mm	+29.3%
BLK BlackRock	0.00	-3.14 mm	EXIT
BlackRock	2.73 mm	+2.73 mm	NEW
MKFCF Mackenzie Financial	3.92 mm	+2.31 mm	+143.4%
AMF Pensionsforsakring AB	1.70 mm	-2.25 mm	-56.9%
Ubs Global Asset Management Americas	12.05 mm	-2.11 mm	-14.9%
Clearbridge Advisors	7.26 mm	-1.78 mm	-19.7%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

News

From Benzinga Pro

Keybanc Maintains Overweight on Alcon, Lowers Price Target to $105

Keybanc analyst Brett Fishbin maintains Alcon (NYSE:ALC) with a Overweight and lowers the price target from $107 to $105.

Apple To $253? Here Are 10 Top Analyst Forecasts For Friday

Needham Maintains Buy on Alcon, Lowers Price Target to $106

Needham analyst David Saxon maintains Alcon (NYSE:ALC) with a Buy and lowers the price target from $108 to $106.

Tesla To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Tuesday

Needham Maintains Buy on Alcon, Raises Price Target to $108

Press releases

From Benzinga Pro

Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference

Alcon (SIX/NYSE:ALC) CEO David Endicott will present at the 2025 J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 4:30 p.m. PST. A live webcast of the conference will be available at

Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation

Third-quarter 2024 sales of $2.4 billion, up 6% on a reported and constant currency1 (cc) basis Third-quarter 2024 diluted EPS of $0.53, up 29%, or 32% cc; core diluted EPS2 of $0.81, up 23%, or 25% cc Generated

Alcon Debuts Groundbreaking PRECISION7, a One-Week Replacement Contact Lens to Start and End Every Week Fresh

PRECISION7, a new one-week replacement lens, provides 16 hours of outstanding comfort and precise vision, even on day 71 Features world's first ACTIV-FLO System specially designed for one-week optimal

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.